Definitive Contract 75R60219C00004

Award Date 9/27/19
Potential Completion Date 9/3/35
Potential Value $63M
Federal Agency
Headquarters
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Health Resources and Services Administration (HRSA) to the New York Blood Center, Inc. (NYBC) to collect and maintain at least 150,000 new cord blood units for the National Cord Blood Inventory (NCBI) over a potential 15-year period. The initial period of performance is 5 years, with options to extend for up to 10 additional years. The contract ceiling value is $15,535,900.00. There is no set-aside designation for this full and open competition....
This is a definitive, firm-fixed price contract awarded by the Health Resources and Services Administration (HRSA) to Duke University to build the National Cord Blood Inventory (NCBI). The contract is valued at $31,801,048 and has an ultimate completion date of September 3, 2035. The contract requires Duke University to operate an established cord blood bank, comply with FDA regulations, and add genetically diverse cord blood units to the NCBI. The units must be made available through the C.W....
This is a $12,160,266.00 firm-fixed-price definitive contract awarded by the Health Resources and Services Administration (HRSA) to Lifesouth Community Blood Centers Inc., a non-profit organization, for the National Cord Blood Inventory (NCBI) program. The contract has a 15-year period of performance ending in September 2034. The contract was awarded as part of a full and open competition to build and maintain the NCBI, which aims to collect and preserve at least 150,000 new, genetically diverse...
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services Health Resources and Services Administration to The Abraham J & Phyllis Katz Cord Blood Foundation, doing business as the Cleveland Cord Blood Center, for the National Cord Blood Inventory program. The contract has a ceiling value of $14,696,652.00 and a completion date of September 26, 2041. There was no set-aside designation used for this award. The contract requires the vendor to...
This is a Definitive Contract awarded by the U.S. Headquarters agency, a civilian agency, to the non-profit organization Gencure (d/b/a The Texas Cord Blood Bank) on September 13, 2007. The contract is for $8,223,699.00 and is a Firm Fixed Price Contract for Management Services/Contract and Procurement Support for the National Cord Blood Inventory Augmentation, Second Cohort. The contract has no set-aside designation and is set to expire on June 12, 2026. The major program code is MGT...
The Department of Health and Human Services awarded a $12,313,923 firm fixed price contract to the New York Blood Center (NYBC), a nonprofit organization, to collect and maintain genetically diverse, high-quality umbilical cord blood units for the National Cord Blood Inventory. This is part of the 5th cohort of the Cord Blood Inventory program. The contract has an ultimate completion date of September 24, 2028 and was awarded on September 10, 2010. There was no set-aside designation for this...
The Department of Health and Human Services Health Resources and Services Administration awarded a $6,581,857.57 Firm Fixed Price contract to The Abraham J & Phyllis Katz Cord Blood Foundation, doing business as Cleveland Cord Blood Center, a tax-exempt non-profit organization and manufacturer of goods. The contract is for the collection and maintenance of genetically diverse, high-quality umbilical cord blood units to be included in the National Cord Blood Inventory. The contract has a...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various cancer types. The award ceiling value is $562,875.00 and the period of performance runs from April 30, 2010 to March 31, 2015. This delivery order is part of the...
This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson) to provide additional funding for a previously awarded contract, 263-MJ-611300. The contract is a firm-fixed-price purchase order with a ceiling value of $100,000.00 and an ultimate completion date of September 30, 2008. The contract does not have a set-aside designation. MD Anderson...
This is a federal contract award made by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The award, valued at $2,387,945.37, is for biomedical research and development activities, with an ultimate completion date of August 21, 2013. The contract is a definitive contract with a cost-no-fee pricing type, and does not have...

This is a firm fixed-price contract awarded by the Health Resources and Services Administration (HRSA) to The University of Texas M.D. Anderson Cancer Center (MD Anderson) to collect and maintain at least 150,000 new cord blood units for the National Cord Blood Inventory (NCBI) over a potential 15-year period. The contract has a ceiling value of $62,742,484.07. The NCBI is established under the Stem Cell Therapeutic and Research Acts to provide a genetically diverse collection of cord blood units for hematopoietic stem cell transplantation through the C.W. Bill Young Cell Transplantation Program. MD Anderson, as a state-controlled academic medical institution, has significant experience in federal research contracts and grants. This contract does not utilize a small business set-aside. The University of Texas System is the parent organization of MD Anderson.

Generated 8/23/25, 9:49 AM